MedPath

An open label single arm clinical study to evaluate the effect of kalyanaka guda in sutika pandu

Phase 3
Conditions
Health Condition 1: I998- Other disorder of circulatory system
Registration Number
CTRI/2023/06/054034
Lead Sponsor
Dr Supriya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects fulfilling diagnostic criteria

2. Age group of 21-34yr

3.Subject irrespective of mode of delivery (like-cesarean, forceps, vacuum delivery)

4.Puerperal women having laboratory findings of Hemoglobin percentage between 7-10.9gm% after 24 hours of post-natal

Exclusion Criteria

1.subjects having Hemoglobin percentage below 7gm%

2.subjects diagnosed with systemic disorders like gestational hypertension, Type 2 Diabetes mellitus, and Renal insufficiency.

3.All types of diagnosed cases of secondary anemia, thalassemia, sickle cell anemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study is expected to cure sutika pandu and to increase Hb in sutikaTimepoint: 45days
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: -
© Copyright 2025. All Rights Reserved by MedPath